scorecardresearch
Add as a preferred source on Google
Tuesday, December 2, 2025
TopicCovid drug

Topic: Covid drug

Free Covid precaution doses for 18-59 age group from July 15 at govt centres

As part of Centre’s Azadi Ka Amrit Mahotsav, this initiative will continue for 75 days.

WHO recommends two new Covid drugs, in discussions to secure ‘equitable access’

Extent to which Baricitinib & Sotrovimab will save lives depends on how available, affordable they will be, says WHO. New guidelines advise against use of Remdesivir, Ivermectin.

WHO approves Glaxo and Eli Lilly drugs to treat Covid amid Omicron surge

Eli Lilly’s rheumatoid arthritis drug and GlaxoSmithKline's monoclonal antibody won the WHO nod.

Antiviral Molnupiravir not in govt Covid protocol, but ‘millions of doses’ distributed in a week

Pharma companies say doctors working in community settings have begun pre-ordering the drug, several manufacturers gearing up to meet demand.

Scientists launch hunt to find naturally Covid-resistant people, 1,000 volunteers to be enrolled

The study looks for people genetically resistant to SARS-CoV-2 virus — if such natural immunity exists. Candidates are one of a couple, where only one partner fell sick, despite close contact.

ICMR drops Ivermectin, Hydroxychloroquine from clinical guidelines for Covid management

Issuing a set of revised guidelines, ICMR advised that Remedesivir should be used only in select Covid patients and use of Tocilizumab should also be in specific circumstances.

No benefits of Doxycycline found in UK Covid patients, write Oxford researchers in Lancet study

According to researchers, the drug that has been commonly used to treat Covid respiratory symptoms does not reduce recovery time, hospital admissions, or deaths related to Covid.

Has Covid exposed limitations of ‘secretive’ ICMR? Some experts think so

The ICMR has increasingly drawn criticism from India's doctors and scientists, who have questioned its drug recommendations & lack of transparency on data related to variants.

Pharma firms and diagnostics developers need to unite. They are catalysts for saving lives

Studies of drugs like remdesivir and hydroxychloroquine were underpowered and small, and the results were conflicting and, in many cases, inconclusive.

Molnupiravir helps in faster recovery of mild Covid patients, says Hetero after phase 3 trials

Hyderabad-based pharma company, Hetero, announced promising interim results of phase 3 trials and has approached DCGI for emergency use authorisation for the drug in India.

On Camera

Media ownership isn’t perfect. It’s worse under Trump: Martin Baron, ex-Washington Post editor

Project Syndicate Deputy Managing Editor Rachel Danna sat down with Martin Baron, former executive editor of the Washington Post, to discuss the state – and fate – of journalism today.

India picks up non-sanctioned Russian oil as discounts widen

The purchases confirm a cautious return to Russian oil, though overall spot purchases remain limited. Trade talks between US and India are ongoing.

Op Sindoor hit Pakistan’s economy hard, we forced their navy to stay restricted to ports—Navy chief

Admiral Dinesh Tripathi at annual media interaction ahead of Navy Day celebrations announced that an operational demonstration is expected at Thiruvananthapuram, President Murmu to attend.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.